Medicure Stock Today
| MPH Stock | CAD 0.89 0.14 18.67% |
PerformanceWeak
| Odds Of DistressLow
|
Medicure is selling for under 0.89 as of the 16th of March 2025; that is 18.67 percent increase since the beginning of the trading day. The stock's lowest day price was 0.89. Medicure has about a 23 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 16th of December 2024 and ending today, the 16th of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Medicure Inc., a pharmaceutical company, engages in the development and commercialization of therapies for the cardiovascular market in the United States. The company was founded in 1997 and is headquartered in Winnipeg, Canada. MEDICURE INC operates under Biotechnology classification in Canada and is traded on TSX Venture Exchange.. The company has 10.44 M outstanding shares of which 3.88 K shares are now shorted by private and institutional investors with about 1.44 days to cover all short positions. More on Medicure
Moving together with Medicure Stock
Moving against Medicure Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Medicure Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Medicure's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Medicure or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Founder, Chairman and CEO | Albert Friesen | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Biotechnology, Healthcare (View all Sectors) | ||||
Medicure's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Medicure's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsMedicure can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Medicure's financial leverage. It provides some insight into what part of Medicure's total assets is financed by creditors.
| |||||
Medicure (MPH) is traded on TSX Venture Exchange in Canada and employs 5 people. Medicure is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 9.29 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Medicure's market, we take the total number of its shares issued and multiply it by Medicure's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Medicure classifies itself under Pharmaceuticals sector and is part of Health Care industry. The entity has 10.44 M outstanding shares of which 3.88 K shares are now shorted by private and institutional investors with about 1.44 days to cover all short positions.
Medicure has accumulated about 45.7 M in cash with 2.08 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.07, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Medicure Probability Of Bankruptcy
Ownership AllocationMedicure holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months.
Check Medicure Ownership Details
Medicure Risk Profiles
Although Medicure's alpha and beta are two of the key measurements used to evaluate Medicure's performance over the market, the standard measures of volatility play an important role as well.
Medicure Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Medicure without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Suggestion Now
Portfolio SuggestionGet suggestions outside of your existing asset allocation including your own model portfolios |
| All Next | Launch Module |
Additional Tools for Medicure Stock Analysis
When running Medicure's price analysis, check to measure Medicure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicure is operating at the current time. Most of Medicure's value examination focuses on studying past and present price action to predict the probability of Medicure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicure's price. Additionally, you may evaluate how the addition of Medicure to your portfolios can decrease your overall portfolio volatility.